DataMeds AI Licensing Deal with REBOOT Health AI, Inc. Worth $2M
DataMeds AI, Inc. entered into an exclusive intellectual property license agreement with REBOOT Health AI to use its AI platform for DataMeds' GLP-1 weight management business. As consideration, DataMeds will issue 666,667 shares of common stock with a guaranteed minimum value of $2 million after 180 days, plus a revenue-sharing arrangement. The company also disclosed it remains below Nasdaq's minimum stockholders' equity requirement for continued listing.
- Value
- $2M
- Counterparty
- REBOOT Health AI, Inc.
- Term
- perpetuity